Market Cap 26.74B
Revenue (ttm) 19.50B
Net Income (ttm) -758.55M
EPS (ttm) N/A
PE Ratio 17.61
Forward PE 18.14
Profit Margin -3.89%
Debt to Equity Ratio 0.69
Volume 1,021,100
Avg Vol 866,226
Day's Range N/A - N/A
Shares Out 962.92M
Stochastic %K 78%
Beta 0.82
Analysts Sell
Price Target $29.65

Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides diagnostic imaging solutions, includes magnetic resonance imaging; X-ray systems; and computed tomography (CT) systems and software comprising detector-based spectral CT solutions; ultrasound imaging solutions focused on diagnosis, treatment planning and guidance for...

Industry: Medical Devices
Sector: Healthcare
Phone: 31 20 597 7777
Address:
Philips Center, Amstelplein 2, Amsterdam, Netherlands
Any_real_help_here
Any_real_help_here Oct. 1 at 9:04 PM
$RMSL $RMD $PHG $FSPKF Superior device! https://www.stocktitan.net/news/RMSL/deltawave-tm-launch-qnkef2xu71u7.html
0 · Reply
highnihilism
highnihilism Oct. 1 at 9:41 AM
$ALKS Alkermes Trade Count: 14 | Total $: 7.9 K | 0.06 × 90-Day Avg $: 135.4 K | Call $: 2.8 K | Put $: 5.2 K | % Single-Leg: 91% | % Multi-Leg: 9% | % Contingent: – $TSLX Sixth Street Specialty Lending Trade Count: 15 | Total $: 2.8 K | 0.06 × 90-Day Avg $: 45 K | Call $: 2.8 K | Put $: 33 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $PHG Koninklijke Philips N.V. Trade Count: 297 | Total $: 16.6 K | 0.40 × 90-Day Avg $: 41.8 K | Call $: 2.8 K | Put $: 13.9 K | % Single-Leg: 96% | % Multi-Leg: 4% | % Contingent: – $VHT Vanguard Health Care ETF Trade Count: 8 | Total $: 3.8 K | 0.34 × 90-Day Avg $: 11.4 K | Call $: 2.8 K | Put $: 1.1 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: –
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Sep. 29 at 10:57 AM
WATCHLIST SEP 29 2025. $BBIO Acoramidis Begins to Reduce Cumulative Cardiovascular Outcomes Within the First Month of Treatment in Patients with ATTR-CM $ENGS American Trust Investment Services Strengthens Executive Leadership Amid Accelerated Investment Banking Growth and Global Expansion $PHG Philips unveils latest CT and MR innovations in radiation therapy, advancing precision cancer care at ASTRO 2025 $VYX Needham Reiterates Buy on NCR Voyix, Maintains $15 Price Target $ENLT Enlight Renewable Energy Secures $390M In Tax Equity Deals For Arizona Solar And Storage Project
0 · Reply
OpenOutcrier
OpenOutcrier Sep. 25 at 12:10 PM
$PHG (-3.4% pre) Philips in talks with US over probes of medical technology imports https://ooc.bz/l/78317
0 · Reply
codefocus
codefocus Sep. 17 at 1:39 PM
0 · Reply
Love_To_Learn
Love_To_Learn Sep. 17 at 10:24 AM
$PHG need u for low stock * sub 3 pt
0 · Reply
swiley
swiley Sep. 12 at 7:07 PM
$PHG Is this the company that got the ventilator recall?
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Sep. 10 at 11:18 AM
$PHG Philips, Philips Foundation, and MedShare Launch Program to Strengthen U.S. Healthcare Readiness for Natural Disasters
0 · Reply
Guptasulo
Guptasulo Sep. 8 at 2:19 PM
$IXHL $RMD $PHG, $MDT Here the reasons why IHL-42X deal in sooner rather than later; Part 1 of 2 Background & Strategic Positioning a. Apnimed: Pre-IND 2018-2019 (private) → Shionogi acquired 50% during Phase 2 b. IXHL: Pre-IND 2021-2022 → RMD missed the Apnimed opportunity c. Key Signal: Dr. Alison Wimms (former RMD advisor on Apnimed) joined IXHL's OSA Clinical Advisory Board (Feb 2025) Timeline to Market • Apnimed: Phase 3 complete → NDA Q3-Q4 2026 • IXHL: 505(b)(2) pathway accelerates timeline → potential 3-month delay becomes irrelevant • Clinical superiority: IHL-42X 83% efficacy vs Apnimed 46.8% (IHL-42X best-in-class recaptures market share) Market Opportunity $5-6B addressable OSA market (moderate-severe cases) Market capture potential: Apnimed 22.6% vs IHL-42X 40% of CPAP market RMD's $5.15B revenue → $2.06B at risk from 40% non-adherent patients Dominant players: RMD, Philips(PHG), Medtronic(MDT)
0 · Reply
Guptasulo
Guptasulo Sep. 8 at 2:19 PM
$IXHL $RMD $PHG $MTD Part 2 of 2 Strategic Signals Post-Phase 2 corporate actions suggest partnership/acquisition: $20M share buyback announced (35% of outstanding shares) 347M warrant cancellation - eliminating dilution overhang $50M cash position - why buyback instead of using funds for Ph3. Investment Thesis RMD cannot afford to miss IXHL after losing Apnimed to Shionogi Superior efficacy + Fast Track potential = competitive timeline advantage Dr. Wimms' consulting, signals intend and clear insight. Corporate actions indicate imminent partnership/acquisition Best-in-class asset no major player can ignore
0 · Reply
Latest News on PHG
Philips bets big on US workers with massive money move

Aug 14, 2025, 11:15 AM EDT - 7 weeks ago

Philips bets big on US workers with massive money move


Koninklijke Philips N.V. (PHG) Q2 2025 Earnings Call Transcript

Jul 29, 2025, 6:08 AM EDT - 2 months ago

Koninklijke Philips N.V. (PHG) Q2 2025 Earnings Call Transcript


Philips announces exchange ratio for 2024 dividend

Jun 5, 2025, 4:00 AM EDT - 4 months ago

Philips announces exchange ratio for 2024 dividend


Philips shareholders approve all proposals at the AGM 2025

May 8, 2025, 12:17 PM EDT - 5 months ago

Philips shareholders approve all proposals at the AGM 2025


Any_real_help_here
Any_real_help_here Oct. 1 at 9:04 PM
$RMSL $RMD $PHG $FSPKF Superior device! https://www.stocktitan.net/news/RMSL/deltawave-tm-launch-qnkef2xu71u7.html
0 · Reply
highnihilism
highnihilism Oct. 1 at 9:41 AM
$ALKS Alkermes Trade Count: 14 | Total $: 7.9 K | 0.06 × 90-Day Avg $: 135.4 K | Call $: 2.8 K | Put $: 5.2 K | % Single-Leg: 91% | % Multi-Leg: 9% | % Contingent: – $TSLX Sixth Street Specialty Lending Trade Count: 15 | Total $: 2.8 K | 0.06 × 90-Day Avg $: 45 K | Call $: 2.8 K | Put $: 33 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $PHG Koninklijke Philips N.V. Trade Count: 297 | Total $: 16.6 K | 0.40 × 90-Day Avg $: 41.8 K | Call $: 2.8 K | Put $: 13.9 K | % Single-Leg: 96% | % Multi-Leg: 4% | % Contingent: – $VHT Vanguard Health Care ETF Trade Count: 8 | Total $: 3.8 K | 0.34 × 90-Day Avg $: 11.4 K | Call $: 2.8 K | Put $: 1.1 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: –
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Sep. 29 at 10:57 AM
WATCHLIST SEP 29 2025. $BBIO Acoramidis Begins to Reduce Cumulative Cardiovascular Outcomes Within the First Month of Treatment in Patients with ATTR-CM $ENGS American Trust Investment Services Strengthens Executive Leadership Amid Accelerated Investment Banking Growth and Global Expansion $PHG Philips unveils latest CT and MR innovations in radiation therapy, advancing precision cancer care at ASTRO 2025 $VYX Needham Reiterates Buy on NCR Voyix, Maintains $15 Price Target $ENLT Enlight Renewable Energy Secures $390M In Tax Equity Deals For Arizona Solar And Storage Project
0 · Reply
OpenOutcrier
OpenOutcrier Sep. 25 at 12:10 PM
$PHG (-3.4% pre) Philips in talks with US over probes of medical technology imports https://ooc.bz/l/78317
0 · Reply
codefocus
codefocus Sep. 17 at 1:39 PM
0 · Reply
Love_To_Learn
Love_To_Learn Sep. 17 at 10:24 AM
$PHG need u for low stock * sub 3 pt
0 · Reply
swiley
swiley Sep. 12 at 7:07 PM
$PHG Is this the company that got the ventilator recall?
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Sep. 10 at 11:18 AM
$PHG Philips, Philips Foundation, and MedShare Launch Program to Strengthen U.S. Healthcare Readiness for Natural Disasters
0 · Reply
Guptasulo
Guptasulo Sep. 8 at 2:19 PM
$IXHL $RMD $PHG, $MDT Here the reasons why IHL-42X deal in sooner rather than later; Part 1 of 2 Background & Strategic Positioning a. Apnimed: Pre-IND 2018-2019 (private) → Shionogi acquired 50% during Phase 2 b. IXHL: Pre-IND 2021-2022 → RMD missed the Apnimed opportunity c. Key Signal: Dr. Alison Wimms (former RMD advisor on Apnimed) joined IXHL's OSA Clinical Advisory Board (Feb 2025) Timeline to Market • Apnimed: Phase 3 complete → NDA Q3-Q4 2026 • IXHL: 505(b)(2) pathway accelerates timeline → potential 3-month delay becomes irrelevant • Clinical superiority: IHL-42X 83% efficacy vs Apnimed 46.8% (IHL-42X best-in-class recaptures market share) Market Opportunity $5-6B addressable OSA market (moderate-severe cases) Market capture potential: Apnimed 22.6% vs IHL-42X 40% of CPAP market RMD's $5.15B revenue → $2.06B at risk from 40% non-adherent patients Dominant players: RMD, Philips(PHG), Medtronic(MDT)
0 · Reply
Guptasulo
Guptasulo Sep. 8 at 2:19 PM
$IXHL $RMD $PHG $MTD Part 2 of 2 Strategic Signals Post-Phase 2 corporate actions suggest partnership/acquisition: $20M share buyback announced (35% of outstanding shares) 347M warrant cancellation - eliminating dilution overhang $50M cash position - why buyback instead of using funds for Ph3. Investment Thesis RMD cannot afford to miss IXHL after losing Apnimed to Shionogi Superior efficacy + Fast Track potential = competitive timeline advantage Dr. Wimms' consulting, signals intend and clear insight. Corporate actions indicate imminent partnership/acquisition Best-in-class asset no major player can ignore
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 14 at 6:47 PM
Philips Plans $150M New Investments In US Manufacturing, R&D: Retail’s On The Fence $PHG $DFAX https://stocktwits.com/news/equity/markets/philips-plans-150-million-new-investments-us-manufacturing-r-and-d/chsRrRhRdOD
0 · Reply
BongJamesBong
BongJamesBong Aug. 14 at 12:09 PM
$PHG CEO featured on morning’s with Maria this morning. They are committing $1B in American investment.
0 · Reply
PremarketAddict
PremarketAddict Aug. 5 at 7:11 PM
NEWS UPDATE $HTGC Snappt Acquires Trigo to Enhance Applicant Trust Platform for Multifamily Housing, Secures $50M Growth Financing $PHG Ultrasound Imaging Dataset Acquisition for Neural Network Training and Associated Devices, Systems, and Methods $W Citi raises price target on Wayfair by more than $60, says tariffs will have less of an impact than feared [CNBC] $LIND Lindblad Expeditions Holdings, Inc. Announces Proposed Private Offering of Senior Secured Notes
0 · Reply
scientificway
scientificway Aug. 3 at 4:32 AM
$PHG check MDXG out, growth for sure, how much after a year
0 · Reply
ZacksResearch
ZacksResearch Jul. 30 at 5:33 PM
Is $PHG's slide a buying opportunity or a warning sign? 📉 Q2 EPS dropped to €0.25 from €0.47 YoY, with comparable sales up 1%. Despite a 6% comparable sales growth in Personal Health, macro uncertainties and tariffs weigh on the stock, down 1.05% pre-market. Discover the full story here 👉 https://www.zacks.com/stock/news/2639698/philips-q2-earnings-and-revenues-decline-year-over-year-shares-fall?cid=sm-stocktwits-2-2639698-body-4880&ADID=SYND_STOCKTWITS_TWEET_2_2639698_BODY_4880
0 · Reply
ZacksResearch
ZacksResearch Jul. 30 at 4:14 PM
$PHG drops after Q2 miss — earnings and revenues both down YoY ⚠️ Macro headwinds and tariffs are hitting hard, dragging the stock lower. See what’s pressuring the outlook here 👉 https://www.zacks.com/stock/news/2639698/philips-q2-earnings-and-revenues-decline-year-over-year-shares-fall?cid=sm-stocktwits-2-2639698-teaser-4835&ADID=SYND_STOCKTWITS_TWEET_2_2639698_TEASER_4835
0 · Reply
TheDayTradingAcademy
TheDayTradingAcademy Jul. 30 at 7:14 AM
European stock markets were higher on Tuesday. buoyed by financials & defense stocks, though Danish stocks logged their biggest 1-day drop of the year as $NVO shares slid after the weight-loss drug maker issued a profit warning. Aerospace & defence stocks rose +2.2% after 3 consecutive days of losses. The new framework trade deal offered zero-for-zero tariffs on aircraft & parts. Airbus & Safran SA rose +1.7% & +2.1%, respectively. Shares of $PHG soared nearly +14% at the market open, after the Dutch consumer healthcare group raised its full-year margin outlook. $CAC40 +0.72%, German $DAX +1.03%, nearing a 52 week high, Italian FTSE +1.23%, after reaching a 52 week high of 41,373.41, Spain’s Ibex +0.90%, near 52 week high, London $FTSE +0.60%, almost at a 52 week high & European STOXX 600 +0.29% at 550.36, with banks rising +1.7% to hit their highest since September 2008, as investors bet on improved profits & resilience in a sector broadly insulated from tariff turmoil.
0 · Reply
Any_real_help_here
Any_real_help_here Jul. 29 at 5:27 PM
$RMSL $RMD $PHG $TNXP Just a reminder of how important this new hire is and the massive expansion about to happen here at Rem. Super happy these prices are still low enough to keep accumulating. Everyone who can afford to drop a few thousand and hold for 6 months or so, will be rewarded handsomely!! John worked for Philips 16.5 years. He has come out of retirement because of the superiority of the Deltawave. Read the article entirely. All longs will finally bank! Amen! https://www.gurufocus.com/news/2977250/deltawave-marketing-plan-rmsl-stock-news
0 · Reply
EasyInvest_eToro
EasyInvest_eToro Jul. 29 at 4:38 PM
Philips $PHG raises 2025 guidance, tariffs look less threatening Philips has raised its 2025 guidance after recalculating the impact of tariffs. The Dutch medical technology giant now expects an adjusted operating margin between 11.3% and 11.8% for 2025, an improvement of 50 basis points compared to its previous outlook. In the first six months, the group reported revenues of €4.33 billion and an operating profit that dropped to €400 million. The improved outlook boosted the stock, which closed up 9.3%, bringing the market capitalization to around €23.2 billion — a gain of roughly €200 million for shareholder Exor. https://etoro.tw/3JFjO8B
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jul. 29 at 10:47 AM
WATCHLIST JUL 29 2025 $JBLU JetBlue And United Get Green Light To Launch Blue Sky Alliance, Boosting Loyalty Perks And Flight Options $UBER WeRide And Uber Grow Abu Dhabi Robotaxi Fleet, Set To Double Rides As Service Expands To High-Demand Urban Areas $WKEY WISeKey Secures WebTrust Seal Across Five Domains, Including Post-Quantum And Network Security Compliance $PHG Indonesia Taps Philips In Multiyear Deal To Expand Image-Guided Therapy Services To Rural And Remote Hospitals Nationwide $DVLT Datavault AI Expands Commercialization Of DataScore And DataValue With IBM watsonx Integration Across Enterprise AI Workflows
0 · Reply
DonCorleone77
DonCorleone77 Jul. 29 at 10:37 AM
$PHG Philips reports Q2 adjusted EPS EUR 0.36 vs. EUR 0.30 last year -- Q2 revenue EUR 4.34B vs. EUR 4.46B last year. -- Backs FY25 comparable sales view up 1%-3% -- Raises FY25 adjusted EBITA margin view to 11.3%-11.8% from 10.8%-11.3%.
0 · Reply
Love_To_Learn
Love_To_Learn Jul. 11 at 11:04 AM
$AKBA $PHG !!!!!!!!!!!!!!!!!!!!!! 4 markets poppers last few days and this morning !
0 · Reply